Greg Whitehead

Greg Whitehead

Company: Rubius Therapeutics

Job title: Chief Quality Officer

Seminars:

Panel Discussion: Donor Selection for Best-in-Class Allogeneic Cell Therapy 9:10 am

Highlighting phenotypic considerations for donor-derived allogeneic cells Considering the manufacturing logistics of donor screening, and working with blood banks and centers to establish donor banks Commenting on the ethical considerations of profiting from a donor-derived productRead more

day: Gold-Star Donor Selection Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.